Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2300305 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Shiwa Soukou-Wargalla und 26 weiteren Autor:innen. Beteiligte Einrichtung: I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Glomerulonephritis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
T regulatory type 1 (Tr1) cells, which are defined by their regulatory function, lack of Foxp3, and high expression of IL-10, CD49b, and LAG-3, are known to be able to suppress Th1 and Th17 in the intestine. Th1 and Th17 cells are also the main drivers of crescentic glomerulonephritis (GN), the most severe form of renal autoimmune disease. However, whether Tr1 cells emerge in renal inflammation and, moreover, whether they exhibit regulatory function during GN have not been thoroughly investigated yet. To address these questions, we used a mouse model of experimental crescentic GN and double Foxp3mRFP IL-10eGFP reporter mice. We found that Foxp3neg IL-10–producing CD4+ T cells infiltrate the kidneys during GN progression. Using single-cell RNA sequencing, we could show that these cells express the core transcriptional factors characteristic of Tr1 cells. In line with this, Tr1 cells showed a strong suppressive activity ex vivo and were protective in experimental crescentic GN in vivo. Finally, we could also identify Tr1 cells in the kidneys of patients with antineutrophil cytoplasmic autoantibody–associated GN and define their transcriptional profile. Tr1 cells are currently used in several immune-mediated inflammatory diseases, such as T-cell therapy. Thus, our study provides proof of concept for Tr1 cell–based therapies in experimental GN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department for General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Christoph Kilian, Lis N Velasquez, Philine Letz, Franziska Bertram, Anastasios Giannou, Morsal Sabihi, Ning Song, Hans-Joachim Paust, Penelope Pelczar, Can Ergen, Christian F Krebs, Samuel Huber
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Soukou-Wargalla, S., Kilian, C., Velasquez, L. N., Machicote, A., Letz, P., Tran, H. B., Domanig, S., Bertram, F., Stumme, F., Bedke, T., Giannou, A., Kempski, J., Sabihi, M., Song, N., Paust, H. J., Borchers, A., Garcia Perez, L., Pelczar, P., Liu, B., …, & Huber, S. (2023). Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300305
Vancouver
Soukou-Wargalla S, Kilian C, Velasquez LN, Machicote A, Letz P, Tran HB, et al. Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2300305
BibTeX
@article{SoukouWargalla2023,
author = {Soukou-Wargalla, Shiwa and Kilian, Christoph and Velasquez, Lis N and Machicote, Andres and Letz, Philine and Tran, Huu Ban and Domanig, Saskia and Bertram, Franziska and Stumme, Friederike and Bedke, Tanja and Giannou, Anastasios and Kempski, Jan and Sabihi, Morsal and Song, Ning and Paust, Hans-Joachim and Borchers, Alina and Garcia Perez, Laura and Pelczar, Penelope and Liu, Beibei and Ergen, Can and Steglich, Babett and Muscate, Franziska and Huber, Tobias B and Panzer, Ulf and Gagliani, Nicola and Krebs, Christian F and Huber, Samuel},
title = {Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2300305}
}
EUVIMED